Increase the Safety of Warfarin Therapy in the Ambulatory Setting - PowerPoint PPT Presentation

1 / 50
About This Presentation
Title:

Increase the Safety of Warfarin Therapy in the Ambulatory Setting

Description:

... questions on diet, lifestyles, medications over the counter medications, herbs, ... Tools continued ' ... Tools. ... – PowerPoint PPT presentation

Number of Views:103
Avg rating:3.0/5.0
Slides: 51
Provided by: christophe123
Category:

less

Transcript and Presenter's Notes

Title: Increase the Safety of Warfarin Therapy in the Ambulatory Setting


1
Increase the Safety of Warfarin Therapy in the
Ambulatory Setting
  • Patient Safety, Satisfaction Revenue

Stephanie Dougherty, RN, BSN Patient Safety
Fellow Virginia Commonwealth University VIPCS
May 15, 2003
2
History and Background
  • 176 bed hospital with 12 Ambulatory Practices
    and 145 physicians participating in Integrated
    Delivery System
  • Coumadin - one of the top 10 most dangerous drugs
    in the ambulatory setting. Literature states
    combination bleeding and embolic events runs 2-
    20 in traditional office based management
  • Adverse Event lets Speak the Truth

3
Half Full Theory
4
Objectives
  • a.. Create a culture in ambulatory care of
    patient safety based on open communication and
    human factor concepts
  • b.. Implement an evidence based, systems based,
    patient centered framework to decrease variation
    in the management of Warfarin therapy in the
    ambulatory setting

5
Objectives
  • c.. Increase patient education, awareness, and
    patient participation in managing healthcare
    safety
  • d.. Implement use of Pont-Of-Care INR testing
    equipment in ambulatory setting to decrease turn
    around time and increase patient/staff
    satisfaction

6
Begin
  • Pilot patient safety project at two hospital
    owned Ambulatory practices
  • Began November to create the new process
  • Conducted Failure Analysis - Flow Diagram or
  • What are we currently doing?

7
Flow Diagram
8
DATA
  • How are we managing our patient education?
  • What best practice algorithm are we using?
  • Is everyone doing the same thing - well?
  • ( reference slide re data collection pre
    implementation)

9
What We Found
  • Found the following
  • Small Snapshot Sample of charts reviewed
  • Only 13 were in target range 80 of the time
  • Use of a basic algorithm only at one practice
    site- large amount of variation
  • Interaction with patient usually a lab draw by
    nurse or technician did not have a Coumadin
    focused assessment by nurse or physician

10
What We Found
  • PT/INR results arrive 1-2 days after patient
    visit
  • Physicians review stack of charts a the end of
    the day for medication orders
  • Needed standard for patient assessment each visit
  • Needed standardized education for patients or
    staff - not sure of hospital based patient
    education is remembered

11
What We Found
  • Nurse time not billed
  • Physician time not billed
  • Heavy reliance on memory
  • Many steps in the process

12
Culture and Patient Safety Concepts
  • Cultivate Patient Safety Thinking- initiate
    culture change- understand basics of error and
    why changes to Coumadin management need to be
    accomplished-story telling
  • Remove blame
  • Look for roots of error in system- fatigue,
    memory, vigilance, production pressure

13
Look Familiar?
14
Human Factors Evaluation
  • Evaluated the intrinsic properties and
    constraints of the current system
  • Noise, interruptions, vigilance, increased
    reliance on memory
  • Cognitive factors stress, workload, fatigue
  • Communication between staff
  • Staff Training

15
Goals from Objectives
  • Decrease reliance on memory- patient, nurse ,
    physician,
  • Decrease variation in assessment , dosing,
    education, use of pharmacies
  • Minimize workspace management-streamline process,
    use evidence based medical tools
  • Add Specific Color to the Coumadin Management
    Tools recognition easier than recall

16
Goals from Objectives
  • Increase patient participation and education-
    Patient becomes partner in co managing Coumadin
    treatment
  • Eliminate 1-3 three day wait for PT/INR
    Laboratory results
  • Immediate results with Point of Care technology
    testing equipment (CoaguCheck)

17
KEEP IT SIMPLE
  • Real Relevant - Simple- and Fun (Gosbee)
  • Develop healthy respect for latent error in any
    new system, process or design
  • Training to Anticipate error- Error will emerge!!
  • ( so ..look for it!)

18
Obstacles to Patient Learning
  • Difficulty comprehending
  • Memory( heavy reliance on)
  • Rushed
  • Minimal connection with concept of personal
    responsibility for monitoring diet, exercise,
    travel, communication re doses missed, illness
    or activity, and concommitant medications

19
Perceived Obstacles to change at the sites
  • Things are ok here
  • This is too much paperwork
  • Not another program
  • What do you mean Patient Safety- were safe!
  • The doctors will never go for this
  • The patients wont like it
  • We are doing too much already

20
Overcome perception of Change
21
BEST PRACTICE
  • Process Tools
  • Algorithm
  • Patient education and increased understanding of
    responsibility
  • Initial Nursing Assessment and Coumadin Visit
    Assessment- drives the discussion re relevant
    questions on diet, lifestyles, medications over
    the counter medications, herbs, activity, illness

22
Tools
  • Evidence Based Algorithm
  • Anticoagulation Log
  • Visit Assessment
  • Follow-up Appointment
  • Pont-of- Care INR Testing

23
Tools to Decrease reliance on MEMORY and
Facilitate Education
  • TOOLS (see your handouts for copies)
  • Announcement to Patients Let the patients (and
    staff!) know there is a change a coming - new
    Point of Care Testing and Benefits
  • Blood for the lab tests is obtained via finger
    stick - No more venipuncture
  • Test results are available within minutes No
    more waiting days for results

24
Tools continued
  • Immediate adjustment of drug dosage, if needed
    No more delay in appropriate therapy and a
    decreased risk of complications
  • Frequent interaction with our healthcare
    professionals, which results in better control of
    therapy and increased opportunity to discuss your
    treatment or education needs

25
Tools- Announcement
  • Announcement- handed out in the lab draw area 3-4
    weeks before the first patient starts on the new
    INR Point of Care Testing/Education
  • Generated interest and excitement for the
    changes

26
Tools..
  • Initial Assessment - leads discussion with
    patient relative to Coumadin and issues of
    concern
  • The Language we use through each piece
    REINFORCES learning about Coumadin and
    precatutions

27
Tools..
  • Patient Responsibility discussion and contract
  • Education checklist matching the patient Guide to
    using Coumadin pamphlet from Bristol-Myers, Squib
    guides the nurse and patient education-
    eliminates reliance on memory (see handouts)
  • The education process reinforces learning about
    Coumadin management for the Patient AND the Staff

28
Point of Care Testing
  • Eliminates call back time immediate results to
    patient, nurse and physician
  • Engaged practitioners in discussion on memory,
    vigilance, pace, interruptions

29
Point of Care testing
  • Our choice - CoaguChek S System ( Roche
    Diagnostics- www.coaguchek.com)
  • Human factors designed with multiple benign
    failure modes - Designed to minimize human error
  • CLIA waived
  • A test system not impacted by lot to lot
    reagent variability thereby minimizes the chances
    of clinically significant changes in test
    results.

30
Education to change culture
  • Incident - literature review root cause
    analysis results
  • All Staff Educated on Anticoagulation Management
    via American Heart Association- Management of
    Oral Anticoagulation Therapy
  • (www.acforum.org)

31
National Quality Forum
  • National Quality Forum- Patient Safety activity
  • Increase safety of anticoagulation management is
    applicable to ambulatory setting.
  • A recommended safe practice is to utilize
    dedicated anticoagulation services that
    facilitate coordinated care management services

32
NQF
  • Examples of implementation
  • Staff Experienced in monitoring anticoagulation
    therapy
  • Reliable patient scheduling and tracking
  • Accessible, accurate and frequent prothrombin
    time (PT)/ Independent Normalized Ration (INR)
  • Patient Specific decision support and interaction
  • Ongoing patient education

33
Narrow the holes of Swiss Cheese
  • Use of appropriate Technology
  • Improved clinician knowledge and error awareness
  • Continuous improvement
  • Evidenced based Medicine for the Anticoagulation
    Algorithm

34
New Improved Process
  • Dramatic increase in patient satisfaction
  • More personal time between nurse and patient
    better education and relationship
  • Patient ownership of Coumadin self management

35
How much is this going to cost?
36
Financial AnalysisTotal Number of Tests
Practice Tests / Week Annual Tests PBFHC 15 78
0 DVFHC 15 780 RFHC 15 780 CFHC
10 520 Total 55 2,860
37
Financial AnalysisMedicare Reimbursement
  • Outside Laboratory
  • Annual Tests 2,860
  • Venipuncture 8,580
  • Annual Revenue 8,580
  • INR Testing
  • Annual Tests 2,860
  • Nurse Visits 67,524.60
  • INR Tests 15,701.40
  • Annual Revenue 83,226

38
Financial AnalysisSupply Costs
  • Outside Laboratory
  • Annual Tests 2,860
  • Venipuncture Supplies 0.22
  • Annual Supply Costs 629
  • POC INR Testing
  • Annual Tests 2,860
  • Strips 14,128.40
  • Control Costs 1,086.80
  • Lancets 572
  • Annual Supply Costs 15,787

39
Financial AnalysisNursing Costs
  • Outside Laboratory
  • Annual Tests 2,860
  • Time Cost (20 min. per test) 943.80
  • Annual Nursing Time 944 hrs.
  • Salary w/ Benefits per hr. 22.32
  • Annual Nursing Costs 21,066
  • INR Testing
  • Annual Tests 2,860
  • Time Cost (15 min. per test) 715
  • Annual Nursing Time 715 hrs.
  • Salary w/ Benefits per hr. 22.32
  • Annual Nursing Costs 15,959

40
Financial AnalysisTotal Annual Expenses
  • Outside Laboratory
  • Supplies for
  • Venipuncture 629
  • Nursing Time 21,066
  • TOTAL Expense 21,695
  • POC- INR Testing
  • Supply Costs 15,787
  • Depreciation on INR machines 960
  • Nursing Time 15,959
  • NJ State Lab
  • Compliance 460
  • Increased Lab License Expense 800
  • TOTAL Expense 33,966

41
Financial AnalysisProfit / (Loss) Statement
  • Outside Laboratory
  • Annual Tests 2,860
  • Revenue 8,580
  • Expenses 21,066
  • Only Loss 12,486
  • INR Testing
  • Annual Tests 2,860
  • Revenue 83,226
  • Expenses 33,966
  • Profit 49,260

42
Patient Outcomes
  • Patient and Practitioners discovering
    relationships between the diets of patients with
    noted sometimes large variation in INR results
  • The education and assessment time spent with
    patient- we are finding new medications added,
    missed doses, changes in level of wellness

43
Patient Satisfaction
  • 100 satisfaction from the Patients they were
    ASKING for the new process
  • If they need to be re stuck they are saying
    its OK- go ahead. Better than the vein
  • New algorithm is being used as standard among
    physicians and residents-
  • Error in dosing already intercepted with the
    algorithm

44
Patient Outcomes
  • Patient and Nurse schedules next appointment
    before patient leaves
  • Missed appointments are tracked and followed up
    promptly- there have not been any missed
    appointments with this new process for the INR
    testing and assessment

45
Patient Safety continues
  • Patient leaves with a copy of the new orders and
    the new appointment date
  • Patients are now calling in to discuss the
    addition of new antibiotics from other MDs and
    what to do about the Coumadin dose

46
Physician Satisfaction
  • Physicians are seeing the time spent on the
    education and assessment of each patient and are
    pleased and impressed with the patients positive
    reaction
  • This process slows down the Production devotes
    time to relationship- and is creating an
    interactive patient safety dynamic with patients
    at the center of the care

47
Go Global.. Speak the Truth Softly
  • Original plan was for 3 owned sites to implement
  • Now up to 5 plan to offer this to all 12 owned
    practices and the 145 physicians in our
    Integrated Delivery System
  • Data collection underway to capture the success
    and other opportunities for improvement

48
About Patient Safety Overcome this..!!!
49
Acknowledgements
  • Dr.Kryzkowski- who showed us that we have an
    opportunity to improved safety
  • Dr. Roksvaag, Dr, Shlimbaum, Dr. Kozakowski,
    Lawrence Grand, Claire Long and Dr. Pickoff for
    showing leadership, support and blessings
  • Dr. Jacky Fein for her support in changing
    culture through education
  • Patty Musselman, Mary Shurts, Betty Cronce,
    Bonnie Adaire for their belief in patient
    safety as a number one priority and who supported
    this process over all the obstacles
  • Karen Swisher and Dr. Eric Silfen- for Patient
    Safety Fellowship and mentoring
  • Dr. Kim Thorne- Northbay Medical Center who
    shared with us all her successful clinic tools

50
  • Thank you!
  • Stephanie Dougherty. RN, BSN
  • Patient Safety Officer- Risk Manger
  • dougherty.stephanie_at_hunterdonhealthcare.org
Write a Comment
User Comments (0)
About PowerShow.com